Avalon Investment & Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.61M	Sell	21,149 -815	-4%	-$67.6K	0.04%	178
2022 Q4	$1.82M	Sell	21,964 -253	-1%	-$20.5K	0.05%	172
2022 Q3	$1.76M	Sell	22,217 -1,393	-6%	-$117K	0.05%	169
2022 Q2	$1.75M	Sell	23,610 -885	-4%	-$66.4K	0.05%	172
2022 Q1	$2.2M	Buy	24,495 +2,765	+13%	+$255K	0.05%	166
2021 Q4	$2.43M	Sell	21,730 -3,623	-14%	-$437K	0.06%	161
2021 Q3	$3.19M	Buy	25,353 +664	+3%	+$85.5K	0.07%	166
2021 Q2	$3.34M	Buy	24,689 +2,153	+10%	+$283K	0.07%	168
2021 Q1	$3.06M	Buy	22,536 +893	+4%	+$134K	0.07%	166
2020 Q4	$3.05M	Sell	21,643 -582	-3%	-$74.5K	0.06%	173
2020 Q3	$2.48M	Sell	22,225 -3,004	-12%	-$337K	0.06%	169
2020 Q2	$2.82M	Sell	25,229 -7,316	-22%	-$721K	0.07%	166
2020 Q1	$2.52M	Sell	32,545 -1,731	-5%	-$153K	0.06%	180
2019 Q4	$3.26M	Sell	34,276 -194	-0.6%	-$16.8K	0.07%	184
2019 Q3	$2.63M	Sell	34,470 -440	-1%	-$36.6K	0.06%	190
2019 Q2	$3.06M	Buy	34,910 +314	+0.9%	+$26.8K	0.07%	182
2019 Q1	$3.13M	Buy	34,596 +248	+0.7%	+$21.1K	0.07%	182
2018 Q4	$2.46M	Buy	34,348 +1,765	+5%	+$142K	0.06%	193
2018 Q3	$3.12M	Buy	32,583 +2,272	+7%	+$220K	0.09%	204
2018 Q2	$2.88M	Sell	30,311 -6,977	-19%	-$641K	0.09%	195
2018 Q1	$3.27M	Buy	37,288 +3,527	+10%	+$322K	0.1%	162
2017 Q4	$2.87M	Buy	33,761 +1,129	+3%	+$94.6K	0.09%	170
2017 Q3	$2.83M	Sell	32,632 -247	-0.8%	-$19.8K	0.09%	161
2017 Q2	$2.54M	Buy	32,879 +427	+1%	+$30.3K	0.08%	169
2017 Q1	$2.25M	Buy	32,452 +3,158	+11%	+$212K	0.08%	173
2016 Q4	$1.73M	Buy	29,294 +108	+0.4%	+$6.67K	0.06%	178
2016 Q3	$1.94M	Buy	+29,186	New	+$1.81M	0.07%	149